However, the results presented in our study clearly indicate that the levels of expression of this protein are associated with DFS and OS in patients with stage IIIB squamous cell carcinoma of the cervix, suggesting that SOD2 expression may be considered a biomarker for cervical disease outcome. This evidence concerns the gene SOD2 and cervicitis.